NORTH-REG Dwell-Time Study
Nordic Urothelial Cancer Research Group Study on Reduced BCG Dwell-Time in High Risk NMIBC
Sponsor: Aalborg University Hospital
A PHASE4 clinical study on Side Effect of Drug, this trial is ongoing. The trial is conducted by Aalborg University Hospital and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE4
-
Sep 2025 — Mar 2026 [monthly]
Active Not Recruiting PHASE4
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE4
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting PHASE4
▶ Show 6 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Jun 2023 — Jan 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Jun 2023 [monthly]
Recruiting PHASE4
-
Mar 2021 — Sep 2022 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Feb 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aalborg University Hospital
- Aarhus University Hospital
- Herlev Hospital
- Jørgen Bjerggaard Jensen
- Karolinska University Hospital
- Landspitali University Hospital
- Odense University Hospital
- Region Örebro County
- Regional Hospital West Jutland
- Rigshospitalet, Denmark
- Sahlgrenska University Hospital
- Zealand University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalborg, Denmark , Aarhus, Denmark , Copenhagen, Denmark , Gothenburg, Sweden , Herlev, Denmark , Herning, Denmark , Odense, Denmark , Reykjavik, Iceland , Roskilde, Denmark , Stockholm, Sweden and 1 more location